Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-23-000203 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
52.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
10.25% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
39.15% · OPTIONAL · VALID
Share-count growth 25th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.shares_outstanding
-2.56% · CORE · VALID
Revenue growth 38th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
2.43% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.35% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
64.01% · CORE · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
31.07% · CORE · VALID
R&D intensity 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.49% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.44% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 211.83%
Current 52.02%
Delta -159.81% Capex Intensity Decreased
Previous 10.55%
Current 10.25%
Delta -0.30% Cash Generation Increased
Previous 37.13%
Current 39.15%
Delta 2.02% Dilution Increased
Previous -3.12%
Current -2.56%
Delta 0.56% Growth Increased
Previous -1.07%
Current 2.43%
Delta 3.50% Inventory Pressure Decreased
Previous 55.56%
Current 13.35%
Delta -42.22% Margin Increased
Previous 63.76%
Current 64.01%
Delta 0.25% Profitability Increased
Previous 30.21%
Current 31.07%
Delta 0.86% R And D Intensity Decreased
Previous 13.77%
Current 13.49%
Delta -0.28% Sbc Intensity Decreased
Previous 2.70%
Current 2.44%
Delta -0.26% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.